Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 22, 2023

BUY
$11.39 - $13.72 $26,197 - $31,556
2,300 Added 4.46%
53,900 $686,000
Q1 2023

Jul 11, 2023

SELL
$10.73 - $13.6 $59,015 - $74,800
-5,500 Reduced 9.63%
51,600 $580,000
Q4 2022

May 17, 2023

BUY
$11.8 - $13.78 $119,180 - $139,178
10,100 Added 21.49%
57,100 $757 Million
Q3 2022

May 16, 2023

SELL
$11.61 - $15.22 $9,288 - $12,176
-800 Reduced 1.67%
47,000 $546 Million
Q1 2022

Apr 21, 2022

SELL
$15.39 - $20.25 $407,835 - $536,625
-26,500 Reduced 35.67%
47,800 $925,000
Q4 2021

Feb 03, 2022

SELL
$15.91 - $18.72 $23,865 - $28,080
-1,500 Reduced 1.98%
74,300 $1.28 Million
Q3 2021

Oct 21, 2021

SELL
$13.06 - $17.24 $346,090 - $456,859
-26,500 Reduced 25.9%
75,800 $1.27 Million
Q2 2021

Aug 13, 2021

BUY
$11.45 - $13.96 $16,029 - $19,544
1,400 Added 1.39%
102,300 $1.37 Million
Q1 2021

Apr 30, 2021

BUY
$11.06 - $12.87 $46,452 - $54,054
4,200 Added 4.34%
100,900 $1.21 Million
Q4 2020

Feb 16, 2021

BUY
$9.33 - $12.48 $272,436 - $364,416
29,200 Added 43.26%
96,700 $1.2 Million
Q3 2020

Nov 12, 2020

SELL
$10.33 - $14.49 $9,297 - $13,041
-900 Reduced 1.32%
67,500 $705,000
Q2 2020

Aug 12, 2020

SELL
$11.49 - $15.26 $83,877 - $111,398
-7,300 Reduced 9.64%
68,400 $956,000
Q1 2020

May 12, 2020

SELL
$8.11 - $15.23 $98,131 - $184,283
-12,100 Reduced 13.78%
75,700 $890,000
Q4 2019

Jan 27, 2020

SELL
$10.28 - $14.38 $101,772 - $142,362
-9,900 Reduced 10.13%
87,800 $1.24 Million
Q3 2019

Oct 22, 2019

SELL
$10.05 - $14.55 $88,440 - $128,040
-8,800 Reduced 8.26%
97,700 $1.03 Million
Q2 2019

Jul 26, 2019

BUY
$13.1 - $14.95 $74,670 - $85,215
5,700 Added 5.65%
106,500 $1.55 Million
Q1 2019

Apr 25, 2019

BUY
$13.69 - $20.06 $290,228 - $425,272
21,200 Added 26.63%
100,800 $1.41 Million
Q4 2018

Feb 07, 2019

SELL
$13.96 - $18.26 $936,716 - $1.23 Million
-67,100 Reduced 45.74%
79,600 $1.39 Million
Q3 2018

Nov 02, 2018

BUY
$13.63 - $15.7 $21,808 - $25,120
1,600 Added 1.1%
146,700 $2.24 Million
Q2 2018

Aug 03, 2018

BUY
$13.44 - $17.59 $1.95 Million - $2.55 Million
145,100 New
145,100 $2 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.